Giorgio Vescovo
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer.
Journal: Thrombosis and haemostasis
Published: January 10, 2024
Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: November 19, 2021
The Role of Cell-Free Plasma DNA in Patients with Cardiorenal Syndrome Type 1.
Journal: Cardiorenal medicine
Published: May 06, 2021
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 11, 2021
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Journal: The New England journal of medicine
Published: March 31, 2020
ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU consensus document: The clinical care pathway of acute heart failure patients from symptom onset to discharge from the emergency department
Journal: Giornale italiano di cardiologia (2006)
Published: May 09, 2019
Plasma Lipopolysaccharide Concentrations in Cardiorenal Syndrome Type 1.
Journal: Cardiorenal medicine
Published: February 11, 2019
Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1.
Journal: Journal of nephrology
Published: January 17, 2019
Data on the stem cells paracrine effects on apoptosis and cytokine milieu in an experimental model of cardiorenal syndrome type II.
Journal: Data in brief
Published: October 11, 2018
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study.
Journal: Thrombosis and haemostasis
Published: August 14, 2018
Stem cells transplantation positively modulates the heart-kidney cross talk in cardiorenal syndrome type II.
Journal: International journal of cardiology
Published: July 31, 2018
Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1.
Journal: Cardiorenal medicine
Published: May 11, 2018
Last Updated: 09/26/2026